Bioinformatics Market Size & Outlook, 2025-2033

Bioinformatics Market Overview

The global bioinformatics market size was valued at USD 17.89 billion in 2024 and is estimated to reach an expected value of USD 20.34 billion in 2025 to USD 56.81 billion by 2033, growing at a CAGR of 13.7% during the forecast period (2025-2033). Rising regulatory and diagnostic requirements, increasing omics research, and the need for advanced data analytics are fueling market expansion. 

Key Market Indicators

• North America dominated the bioinformatics industry and accounted for a 45% share in 2024.
• Based on technology & service, the bioinformatics services segment is projected to hold the largest share of about 43% in 2024, expanding at a CAGR of 23.1%
• Based on application, the genomics segment is witnessing steady growth, driven by a rise in government spending and initiatives in genetic research.
• Based on the sector, the medical bioinformatics segment dominated the bioinformatics industry in 2024 due to high investment in genomic research.

Market Size & Forecast

• 2024 Market Size: USD 17.89 billion
• 2033 Projected Market Size: USD 56.81 billion
• CAGR (2025–2033): 13.7%
• Largest market in 2024: North America
• Fastest-growing region: Europe

The field of bioinformatics combines biology and information technology. It connects biological data with information collection, distribution, and evaluation tools to serve numerous aspects of scientific research, such as biomedicine. It utilizes several software tools for database construction, data management, warehousing, and mining. Data mining yields scientific discoveries applied to the study of genetics and genomes. Combining computer programming, big data, and biology, bioinformatics enables scientists to comprehend and detect patterns in biological data. It is valuable in studying genomes and DNA sequencing since it allows scientists to arrange vast amounts of data. There are a variety of bioinformatics tools on the market. These are protein functional and analysis tools, homology and similarity tools, sequence analysis tools, and other tools.

The future growth of the worldwide bioinformatics market is anticipated to be significant due to the rising need for integrated data and the expansion of proteomics and genomics. In addition, medication discovery and development are anticipated to fuel market expansion over the projection period. During the forecast period, however, a shortage of experienced individuals and standard data formats is expected to impede market expansion. In contrast, the rising demand for integrated solutions and systems is anticipated to create lucrative opportunities for market participants.

To get more insights about this report Download Free Sample Report

Bioinformatics Market Growth Factors

The Growing Demand for Integrated Data and Development in Proteomics & Genomics

Investigations and clinical trial procedures, such as drug discovery procedures, create essential data. High-throughput screening and target identification are two other vital applications that generate a considerable volume of data and need efficient analysis. The field of bioinformatics is constantly at work towards building a wide variety of tools that can manage extensive and intricate data sets. These solutions streamline the process of delivering necessary data to end users. As a result, organizations in the pharmaceutical and biotechnology industries are drawn to these applications to handle their data. This propels growth in the bioinformatics market.

The number of studies being carried out in the field of OMICS (genomics, proteomics, and metabolomics) is continuously increasing, which helps boost the number of applications used in bioinformatics. It is anticipated that the OMICS technology would increase data analysis and storage demand. In proteomics and genomics, the platform and methodologies of bioinformatics play an essential part in collecting, analyzing, classifying, and characterizing information. This information contributes to the expansion of research in proteomics and genomes, which in turn aids in identifying treatments and preventative measures for various disorders. Thus, it boosts the market for bioinformatics growth. 

Market Restraining Factors

The Scarcity of Skilled Personnel

The shortage of qualified individuals is one of the issues restraining the expansion of the market. Because an enormous amount of data needs to be processed, the tools utilized in bioinformatics are now only accessible to highly trained end users. This demands staff who are both skilled and professional. In addition, the nature of the job performed by bioinformatics software is complex, which adds to the high expenses of operating the instruments. Because of this, personnel who perform the task must undergo training, which hinders the expansion of the market.

Market Opportunity

The Growth in the Need for Integrated Solutions & Systems

Product development and engineering must be innovative to remain competitive in the medical device sector. The area of bioinformatics is viewed as an information technology tool that deals with the recording, annotation, storage, analysis, and retrieval of nucleic acid sequences, protein sequences, and structural information. On the other hand, the bioinformatics industry is undergoing a progressive shift and is increasingly seen as an integrated instrument. The software utilized in bioinformatics is capable of integrating the data analysis and administration required for diverse applications, like genome sequencing. In addition, it has numerous applications in health and biology, including molecular medicine, preventive medicine, gene therapy, drug development, biotechnology, and forensic microbiology. Consequently, there is a growing demand for integrated solutions and systems in the healthcare sector. This further creates growth opportunities for the bioinformatics market share.

Regional Analysis

North America dominated the bioinformatics market with a 45% share in 2024 and is projected to command the market with the largest share while growing at a CAGR of 12.4% over the forecast period. The region's growth is attributable to increased demand for novel medication research and development and commercial and public funding initiatives to support research and development, which are anticipated to drive market expansion. In addition, the adoption of modern technology and the growing use of bioinformatics tools in Canada and Mexico are expected to stimulate the regional market. Moreover, the federal government regulates bioinformatics in the United States, which involves using health and genetic information to identify persons. Regulations shape the sector by limiting the disclosure of sensitive information and removing obstacles to collecting and processing electronic health and genetic records. This reduction of technological barriers makes bioinformatics user-friendly, hence fostering regional development.

Europe's Market Trends

Europe will hold a share of USD 12,666 million, growing at a CAGR of 14.2%. The region's expansion is attributable to the demand for bioinformatics tools for accurate and rapid analysis of biomarker discovery programs, which aid in toxicity detection during the drug development process. In addition, governments concentrate on numerous programs to promote the advantages of bioinformatics by increasing funding in research and development, which has a favorable impact on the bioinformatics business in European Union nations. Certain obstacles impede the expansion of the market in Europe. Many European companies are hesitant to employ bioinformatics solutions because they believe these tools are limited to a small subset of end users. The market for bioinformatics in Europe is fragmented and slowly consolidating through acquisitions and mergers. Other life science sectors that rely on investments and partnerships with the bioinformatics market share are also anticipated to flourish.

Technology & Service Insights

The bioinformatics services segment is projected to hold the largest share of about 43% in 2024 and expand at a CAGR of 23.1% over the forecast period. Increases in data sequencing and analysis in the bioinformatics sector contribute to developing bioinformatics business services. The service industry is in its expansion phase and is anticipated to be profitable in the long run if it continues to receive excellent client feedback. Increased data extraction and consulting usage have resulted in a significant expansion of the service business. Outsourcing services like the pharmaceutical and medical device industries use bioinformatics organizations to obtain research data quickly. Due to technological improvements, multiple sequence alignment and high-throughput sequencing are the most profitable sections of the sequencing services market.

The knowledge management tools segment will hold the second-largest share. A knowledge management system (KMS) facilitates biological data collection, storage, and dissemination. Rapid changes in global competition, the expansion of information technology, and the development of low-cost storage technologies have permitted a paradigm shift in drug discovery. Almost all chemical and pharmaceutical firms rely heavily on knowledge management. They are creating new chemoinformatic units to support existing drug discovery projects. In addition, the growing demand for data integration, the increase in clinical trials, and the expansion of proteomic data all contribute to the development of the market. 

Application Insights

The genomics segment is projected to expand at a CAGR of 11.3% and hold the largest market share. Genomics is the merging of genetics and bioinformatics that employs DNA and its sequencing techniques to assemble, analyze, and sequence the structure and function of genomes (DNA). Genomics applications include fine-scale genetic mapping and the sequencing of the whole DNA of living creatures. The expansion of the genomics sector is projected to be fueled by a rise in government spending and initiatives in genetic research. Due to its primary emphasis on drug discovery, the genomics market is anticipated to expand substantially within the personalized pharmaceuticals sector.

The chemoinformatics & drug design segment will hold the second-largest share. The definition of chemoinformatics is gathering resources to convert data into useful information and then into knowledge. And the drug development process involves the identification and optimization of potential leads. Lead identification facilitates activity in the low micromolar range, whereas lead optimization facilitates the transformation of leads into therapeutic candidates. There is a need for enhanced chemoinformatic systems due to the explosion of raw data from high-throughput sequencing (HTS) and library creation. Incorporating drug discovery and chemical information is anticipated to aid in enhancing the drug discovery process, facilitating small-scale enterprises' participation in drug discovery research.

Sector Insights

The medical bioinformatics segment is projected to expand at a CAGR of 8.7% and hold the largest market share. Medical bioinformatics is a developing field that focuses on the study, development, and use of algorithms and frameworks to enhance the comprehension, communication, and management of medical data. In the bioinformatics industry, medication development is a critical application because it substantially lowers the cost and time related to drug research. Genomic solutions are utilized in numerous applications, including pharmaceutical innovation and production, solutions support and development, and other medical requirements. This is an excellent opportunity for the bioinformatics industry due to the rise of the genomics industry, which gives several options for the life science industry.

The other segment will hold the second-largest share. Others include microbial genome research, trash cleanup, climate change studies, and alternative energy sources. Microorganisms are prevalent, and it is simple to comprehend the base level of microbes by examining the genetic material of these organisms. In addition, the isolation of genes facilitates the comprehension of their uniqueness, which helps them to thrive in severe environments. Climate Change Studies, Evolutionary Studies, Bioweapon Creation, Waste Cleanup, Biotechnology, Antibiotic Resistance, Alternative Energy Sources, and Forensic Analysis of Microbes are various microbial genome applications.

List of key players in Bioinformatics Market

1. Accelrys, Inc.
2. Affymetrix, Inc.
3. Agilent Technologies, Inc.
4. Geneva Bioinformatics
5. SA Nonlinear Dynamics
6. Quest Diagnostics, Inc.
7. Illumina
8. Bruker Daltonics Inc.
9. Biomax Informatics AG
10. Life Technologies Corporation
11. Sanofi
12. BioNTech
13. BioInvent
14. Juvenescence

To get more findings about this report Download Market Share

Recent Developments

• July 2025: Sanofi completed its acquisition of Blueprint Medicines for a total of $9.5 billion. This deal adds Blueprint's cancer drug pipeline to Sanofi's portfolio.
• June 2025: BioNTech took over CureVac for $1.25 billion to acquire its mRNA vaccine program for cancer and infectious diseases.
• June 2025: BioInvent presented promising Phase 2a monotherapy data for its BI-1808 drug in CTCL at EHA 2025
• June 2025: Juvenescence bought Ro5 to boost its drug discovery efforts with artificial intelligence. Ro5 employs its AI Chemistry platform to design new molecules against drug targets.